• Most Popular
  • Most Shared

GSK gets Japanese approval for Advair, Arixtra

Wed Apr 18, 2007 3:09am EDT

Stocks

   

LONDON, April 18 (Reuters) - GlaxoSmithKline Plc (GSK.L) said on Wednesday it had received Japanese approval for asthma drug Advair, which is also known as Seretide, and anti-thrombotic treatment Arixtra.

Regulatory News

"We expect sales of Seretide/Advair in Japan will make a significant contribution to worldwide sales of this important GSK product," Europe's biggest drugmaker said in a statement.

"The additional news, that Arixtra is also approved today...is further evidence of a strong product pipeline coming to fruition in this key international market."

Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets